Esperto Medical has been awarded a Phase I Small Business Innovation Research (SBIR) award from the Advanced Research Projects Agency for Health (ARPA-H) Scalable Solutions Mission Office to develop its next-generation continuous blood pressure monitoring solution.
The project, titled "Continuous, Non-invasive, Calibration-Free Blood Pressure Monitoring by Resonance Sonomanometry," will adapt Esperto's proprietary resonance sonomanometry (RSM) technology into a wearable, wireless device suitable for home and ambulatory blood pressure monitoring.
Esperto's RSM technology offers a different approach to traditional monitoring methods that rely on calibration to periodic cuff measurements. By measuring blood pressure directly using ultrasound-based resonance sensing, RSM enables continuous measurement without the need for calibration. The Phase I effort will complete the technical planning necessary for miniaturizing Esperto's platform into a wearable device capable of providing more accurate and convenient monitoring in everyday and remote settings.
"This ARPA-H award directly aligns with Esperto's strategy of translating the RSM technology into a wearable remote patient monitoring device," said Esperto Chief Medical Officer and Co-Founder Alaina Rajagopal in a statement. "Because RSM measures blood pressure directly rather than inferring it from other physiologic signals, and because it requires no calibration, we believe it offers significant advantages as a user-friendly and clinically reliable remote monitoring solution."
